Form D · Biotechnology
Gong Sheng Yuan Biotechnology Corp
Hangzhou, F4 · CIK 0002004372
Offering snapshot reported Dec 14, 2023 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 200 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 14, 2023 | Initial | Yet to sell | No comparison | 200 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- Yes
- Sales commissions
- $500K (estimated)
- Finders' fees
- $500K (estimated)
- Form D file number
- 021-499623
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| HUIDONG INTERNATIONAL INC. | 3889981 |
Source: Form D, filed Dec 14, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Changchun Tang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
626 Science Museum Street
Hangzhou, F4, 310051
Hangzhou, F4, 310051